Skip to main content
. 2020 Jul 28;111(9):3386–3394. doi: 10.1111/cas.14564

FIGURE 3.

FIGURE 3

Purpose of using PDX models in the development of anticancer drugs and required supports for the utilization of PDX models. A, Current purpose of academic researchers (total respondents: 19). B, Current purpose of researchers in pharmaceutical companies (total respondents: 6). C, Future purpose of researchers in each group. Total number of respondents was 3 (researchers at development divisions of pharmaceutical companies), 5 (researchers at research divisions of pharmaceutical companies), 19 (academic researchers using PDX models), and 15 (academic researchers not using PDX models). D, Results from the questionnaire on required support of academic researchers (total respondents: 34). E, Results from the questionnaire on required support of researchers from research divisions of pharmaceutical companies (total respondents: 5)